Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.
1990
987
LTM Revenue $460M
LTM EBITDA $25.7M
$380M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Accuray has a last 12-month revenue of $460M and a last 12-month EBITDA of $25.7M.
In the most recent fiscal year, Accuray achieved revenue of $447M and an EBITDA of $5.7M.
Accuray expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Accuray valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $430M | $448M | $447M | $460M | XXX |
Gross Profit | $160M | $154M | $143M | XXX | XXX |
Gross Margin | 37% | 34% | 32% | XXX | XXX |
EBITDA | $11.6M | $8.4M | $5.7M | $25.7M | XXX |
EBITDA Margin | 3% | 2% | 1% | 6% | XXX |
Net Profit | -$5.3M | -$9.3M | -$15.5M | XXX | XXX |
Net Margin | -1% | -2% | -3% | XXX | XXX |
Net Debt | $91.7M | $87.9M | $104M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 14, 2025, Accuray's stock price is $2.
Accuray has current market cap of $229M, and EV of $380M.
See Accuray trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$380M | $229M | XXX | XXX | XXX | XXX | $-0.07 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 14, 2025, Accuray has market cap of $229M and EV of $380M.
Accuray's trades at 0.8x LTM EV/Revenue multiple, and 14.8x LTM EBITDA.
Analysts estimate Accuray's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Accuray and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $380M | XXX | XXX | XXX |
EV/Revenue | 0.8x | XXX | XXX | XXX |
EV/EBITDA | 21.8x | XXX | XXX | XXX |
P/E | -28.2x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAccuray's NTM/LTM revenue growth is 5%
Accuray's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Accuray's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Accuray's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Accuray and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 0% | XXX | XXX | XXX | XXX |
EBITDA Margin | 4% | XXX | XXX | XXX | XXX |
EBITDA Growth | -32% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 9% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 10% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 11% | XXX | XXX | XXX | XXX |
Opex to Revenue | 32% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Electromed | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Accuray acquired XXX companies to date.
Last acquisition by Accuray was XXXXXXXX, XXXXX XXXXX XXXXXX . Accuray acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Accuray founded? | Accuray was founded in 1990. |
Where is Accuray headquartered? | Accuray is headquartered in United States of America. |
How many employees does Accuray have? | As of today, Accuray has 987 employees. |
Who is the CEO of Accuray? | Accuray's CEO is Ms. Suzanne C. Winter. |
Is Accuray publicy listed? | Yes, Accuray is a public company listed on NAS. |
What is the stock symbol of Accuray? | Accuray trades under ARAY ticker. |
When did Accuray go public? | Accuray went public in 2007. |
Who are competitors of Accuray? | Similar companies to Accuray include e.g. Philips, Perspective Therapeutics, Electromed, InfuSystem. |
What is the current market cap of Accuray? | Accuray's current market cap is $229M |
What is the current revenue of Accuray? | Accuray's last 12-month revenue is $460M. |
What is the current EBITDA of Accuray? | Accuray's last 12-month EBITDA is $25.7M. |
What is the current EV/Revenue multiple of Accuray? | Current revenue multiple of Accuray is 0.8x. |
What is the current EV/EBITDA multiple of Accuray? | Current EBITDA multiple of Accuray is 14.8x. |
What is the current revenue growth of Accuray? | Accuray revenue growth between 2023 and 2024 was 0%. |
Is Accuray profitable? | Yes, Accuray is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.